<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01256866</url>
  </required_header>
  <id_info>
    <org_study_id>hsd130947</org_study_id>
    <nct_id>NCT01256866</nct_id>
  </id_info>
  <brief_title>Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine</brief_title>
  <official_title>Sedation of Mechanically Ventilated Critically Ill Patients: Midazolam Versus Dexmedetomidine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sao Domingos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sao Domingos</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomized study is to compare the safety and efficacy of two
      strategies for sedation of critically ill patients submitted to mechanical ventilation:
      continuous intravenous infusion of dexmedetomidine versus intravenous bolus of midazolam. The
      two groups will be compared as to the incidence of of delirium, evaluated with the Confusion
      Assessment Method for ICU (CAM-ICU) and the percentage of time within the target sedation
      using the Richmond Agitation-Sedation Scale (RAAS).Eligible patients will be 18 years or
      older intubated and mechanically ventilated for less than 48 hours prior to start of study
      drug and anticipated ventilation duration of at least 48 hours. Calculated sample size is 146
      patients (73 patients in each group)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of delirium</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>PERCENTAGE OF TIME WITHIN THE TARGET SEDATION</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">146</enrollment>
  <condition>Mechanically Ventilated Patients</condition>
  <condition>Sedation</condition>
  <condition>Dexmedetomidine</condition>
  <condition>Midazolam</condition>
  <arm_group>
    <arm_group_label>DEXMEDETOMIDINE, SEDATION</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam, sedation,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>DEXMEDETOMIDINE, SEDATION</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <arm_group_label>Midazolam, sedation,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult mechanically ventilated, critically ill patients

        Exclusion Criteria:

          -  pregnancy or lactation, severe liver disease, hearth rate less than 50, hypotension
             despite volemic repletion and vasoactive drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Sao Domingos</name>
      <address>
        <city>Sao Luis</city>
        <state>Maranhao</state>
        <zip>65060-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose R Azevedo, MD</last_name>
      <phone>55 98 32168110</phone>
      <email>jrazevedo@elo.com.br</email>
    </contact>
    <investigator>
      <last_name>Jose R Azevedo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carla C Oliveira, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2010</study_first_submitted>
  <study_first_submitted_qc>December 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2010</study_first_posted>
  <last_update_submitted>December 8, 2010</last_update_submitted>
  <last_update_submitted_qc>December 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ethics Committee</name_title>
    <organization>Hospital Sao Domingos</organization>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Midazolam</keyword>
  <keyword>Sedation</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Critically ill patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

